KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0023 | - |
9,10-phenanthrenequinone | - |
Sus scrofa | |
0.0052 | - |
NADPH | - |
Sus scrofa | |
0.16 | - |
prostaglandin E2 | - |
Sus scrofa | |
0.31 | - |
menadione | - |
Sus scrofa | |
0.45 | - |
4-nitrobenzaldehyde | - |
Sus scrofa |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
28000 | - |
gel filtration, 4 isoforms | Sus scrofa |
32000 | - |
alpha, 1 * 32000, SDS-PAGE | Sus scrofa |
34000 | - |
alpha, 1 * 34000, SDS-PAGE | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Sus scrofa | - |
- |
- |
Purification (Comment) | Organism |
---|---|
- |
Homo sapiens |
- |
Sus scrofa |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
kidney | - |
Homo sapiens | - |
kidney | - |
Sus scrofa | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.02 | - |
- |
Sus scrofa |
0.034 | - |
- |
Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate + NAD(P)+ | - |
Homo sapiens | (5Z,13E)-11alpha-hydroxy-9,15-dioxoprosta-5,13-dienoate + NAD(P)H | - |
? | |
(5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate + NAD(P)+ | - |
Sus scrofa | (5Z,13E)-11alpha-hydroxy-9,15-dioxoprosta-5,13-dienoate + NAD(P)H | - |
ir | |
(5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate + NADP+ | - |
Homo sapiens | (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate + NADPH + H+ | - |
? | |
(5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate + NADP+ | - |
Homo sapiens | (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate + NADPH + H+ | - |
r | |
(5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate + NADP+ | enzyme is pro(S) stereo selective with regard to hydrogen transfer from NADPH | Sus scrofa | (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate + NADPH + H+ | - |
r | |
(5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate + NADP+ | - |
Homo sapiens | (5Z,13E)-9alpha,11alpha-dihydroxy-15-oxoprosta-5,13-dienoate + NADPH + H+ | - |
? | |
(5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate + NADP+ | - |
Sus scrofa | (5Z,13E)-9alpha,11alpha-dihydroxy-15-oxoprosta-5,13-dienoate + NADPH + H+ | - |
ir | |
(5Z,13E)-(15S)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate + NADP+ | - |
Homo sapiens | (5Z,13E)-9alpha-hydroxy-11,15-dioxoprosta-5,13-dienoate + NADPH | - |
? | |
(5Z,13E)-(15S)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate + NADP+ | - |
Sus scrofa | (5Z,13E)-9alpha-hydroxy-11,15-dioxoprosta-5,13-dienoate + NADPH | - |
ir | |
17alpha-hydroxyprogesterone + NADPH | - |
Sus scrofa | ? | - |
? | |
2,6-dichloroindophenol + NADPH | - |
Sus scrofa | ? | - |
? | |
4-nitrobenzaldehyde + NADPH | - |
Sus scrofa | ? | - |
? | |
5alpha-dihydrotestosterone + NADPH | - |
Sus scrofa | ? | - |
? | |
9,10-phenanthrenequinone + NADPH | - |
Sus scrofa | ? | - |
? | |
alpha-tocopherolquinone + NADPH | - |
Sus scrofa | ? | - |
? | |
corticosterone + NADPH + H+ | - |
Sus scrofa | ? | - |
? | |
cortisole + NADPH | - |
Sus scrofa | ? | - |
? | |
menadione + NADPH | - |
Sus scrofa | ? | - |
? | |
phenylglyoxal + NADPH | - |
Sus scrofa | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
monomer | alpha, 1 * 34000, SDS-PAGE | Homo sapiens |
monomer | alpha, 1 * 32000, SDS-PAGE | Sus scrofa |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
- |
Homo sapiens |
37 | - |
- |
Sus scrofa |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.8 | 9 | - |
Sus scrofa |
8 | - |
- |
Sus scrofa |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NADPH | - |
Homo sapiens | |
NADPH | - |
Sus scrofa |